|
Value Vault: Archived Analysis
NOTE: This page has been archived and the commentary, data, and links on this page are current as of the last date indicated.
|
Decoma International Inc. (TSX:DEC.A)
|
|
 |
|
|
 |
 |
|
|
| ABOUT THE COMPANY |
|
Decoma International Inc. is a major international auto
parts supplier of exterior vehicle appearance components and systems. The
Company designs, engineers and manufactures fascias (bumpers), front and rear
end modules, plastic body panels, roof modules, exterior trim components,
sealing and greenhouse systems and lighting components. Decoma employs
approximately 15,000 people in 49 facilities in Canada, the United States,
Mexico, Germany, Belgium, England, France, Austria, Poland, the Czech Republic
and Japan. Magna International maintains effective control over Decoma with an
approximately 74% ownership stake in the Company. |
|
 |
|
|
| FINANCIAL DATA |
| |
2001 |
2002 |
2003 |
| Earnings per Share ($) |
1.00 |
1.30 |
0.88 |
| Price to FFO |
8.0 |
6.2 |
9.1 |
| Dividend ($) |
0.28 |
0.28 |
0.28 |
| Dividend Yield (%) |
3.50 |
3.50 |
3.50 |
| Book Value ($) |
5.77 |
5.33 |
7.35 |
| Price to Book Value (times) |
1.39 |
1.50 |
1.09 |
|
|
|
| PRICE GRAPH |
 |
|
 |
|
|
| WHY ABC FUNDS BOUGHT THIS COMPANY |
|
Decoma was spun out from Magna on March 2, 1998 and began trading on the TSX
under the symbol DEC.a and on the NASDAQ under the symbol DECA. The auto parts
industry is notoriously cyclical and is driven primarily by interest rates,
consumer confidence and employment levels. However, historically low interest
rates and aggressive incentive programs have bolstered sales over the course of
the current cycle. Looking at the historic trading pattern, the shares have
moved from an issue price of $9.50 CDN to a high of $21.10 CDN on June 4, 2002,
and back to roughly $10 CDN today.
Decoma reports in US dollars and in 2003 generated $2.4 billion in sales, an
increase of 15% from 2002. Net income declined to $71.9 million or $0.88 per
basic share in 2003 from $93.0 million or $1.30 per basic share in 2002. The
financial results were negatively impacted in 2003 by an impairment charge for
certain United Kingdom assets of $12.4 million and by consolidation charges for
European paint facilities of $11.4 million. We expect that Decoma will report
improving financial results going forward as the European operations work
through start up issues and new programs come on stream through 2005.
Decoma, and most stocks in the auto parts sector, have come under selling
pressure related to several major issues. As we mentioned, auto parts are
cyclical stocks that typically under perform in a rising rate environment.
Further, volatile economic data, including key consumer confidence and
employment growth figures, have added to the uncertainty. Skyrocketing oil
prices have also negatively impacted the outlook for auto sales, especially
sales of SUVs and light trucks. Tier 1 auto parts manufacturers, such as Decoma,
are also facing demands from the OEMs for price concessions, as they try to
maintain market share and boost their own profitability. On the manufacturing
side, raw material costs have spiked, with steel and resin prices rising
dramatically. Finally, Decoma has several facilities and programs ramping up,
which hinders profitability until the product launch is well underway. With all
of these influencing factors, investors have been frightened off; it is no
wonder that Decoma has declined to near six-year lows.
We believe that Decoma is cheap, on an absolute basis, on an historical basis
and relative to its peers. The Company pays a dividend of $0.28 per share in US
dollars, which yields approximately 3.5% in Canadian dollar terms. Book value is
approximately $7.58 US and it trades roughly at book value. Consensus earnings
estimates are $0.93 US for 2004 and $1.11 US in 2005 with the stock trading well
below 10 times this year’s and next year’s earnings. Auto parts stock typically
bottom at these valuation levels. On a relative basis, Decoma trades well below
its peers based on yield, P/BV and P/E metrics. While the Company may experience
a weak quarter or two, we are comfortable that downside risk is limited at
current price levels.
Given the reasonable margin of safety, we would like to point to several
factors that could drive the performance of the stock over the next 12 to 18
months. First, we believe that the US Federal Reserve will raise rates at a
measured and cautious pace that will not damage the economy or consumer
spending. Next, Decoma has several major product launches through 2005, as the
OEMs revamp and refresh their model lines. Look for new or restyled cars from
Ford (Cross Trainer, Five Hundred and Montego), Daimler-Chrysler (Cherokee), GM
(Canyon/Colorado) and Mercedes (A Class). So far this year, Decoma has been a
beneficiary of strong sales of Chrysler’s new 300C sedan, available with the
ferocious Hemi engine. The earnings improvement at Decoma coupled with less
negative sentiment toward the auto parts sector should reward investors over the
next 12 to 18 months.
ABC Funds
October 1, 2004 |
|
 |
|
|
| UPDATES |
| October 29, 2004
On October 1, we selected Decoma as an ABC Funds Value
Favourite. We highlighted the reasons why it was cheap: the cyclical nature
of the stock in a rising rate environment, volatile economic data,
skyrocketing oil prices, OEM price concessions and program ramps that
constrained profitability. We also pointed to several factors that could
drive the performance of the stock over the coming 12 to 18 months: a
measured pace of interest rate hikes, the end the program ramp period and
associated improving profitability.
Decoma’s parent Company, Magna International,
apparently saw the situation in a similar light and on October 25 announced
the privatization of its three subsidiaries: Decoma, Intier and Tesma.
Shareholders were offered a combination of cash and stock, valuing Decoma at
0.1453 of a Magna share, Intier at 0.3847 of a Magna share and Tesma at
0.4388 of a Magna share. Based on the volume-weighted average trading prices
over 20 trading days ended October 22, the proposal offered a premium of
26.3% for Decoma, 36.5% for Intier and 33.3% for Tesma.
Although we were thrilled to receive a privatization
offer, we noted that Decoma was offered the skinniest premium on an already
depressed valuation. In fact, the other two subsidiaries traded up to
52-week highs, while Decoma was still below its high of $14.55. Independent
committees have been established to prepare complete valuations and assess
the fairness of each offer. We believe that it is possible that a
longer-term perspective could result in a sweetened bid for Decoma. We are
monitoring the situation closely and are carefully weighing the potential
upside relative to the current share price.
February 18, 2005
Decoma International and parent company Magna Corp. have entered into an
agreement to take the company private, subject to court approval and
shareholder ratification. Under the proposal, shareholders of Decoma will
receive 0.1453 of a class A subordinate voting share of Magna for each class
A subordinate voting share of Decoma they own. There would also be a cash
option based on the volume-weighted average trading price of Magna shares on
the TSX over the five trading days immediately preceding the effective date
of the plan. However, the aggregate cash payable to Decoma shareholders will
be capped at $150 million. If that figure is exceeded, the total cash
available will be prorated among those shareholders who choose the payment
option and the balance will be paid in Magna shares.
Decoma will hold a special shareholders’ meeting later this month in
Toronto and if the plan is approved it is expected to become effective on
March 6. The arrangement will require approval of two-thirds of the votes
cast by holders of Decoma class A and class B shares, with each class voting
separately.
We were not anticipating a take-out of Decoma this quickly but now that
it has happened we believe that the big money has been made. Because the
fundamentals have yet to improve, the Magna offer was fortuitous. We are
monitoring the situation closely and are considering the risk/reward
relationship carefully. We will update our comment again as further events
warrant.
March 11, 2005
Magna’s privatization of Decoma received shareholder approval and became
effective on March 6, 2005. Magna will issue 2,854,400 Class A shares in
exchange for Class A shares of Decoma and will pay approximately $37.2
million to shareholders who elected the cash option. Based on the
volume-weighted average trading price of Magna over the five trading days
ended March 4, 2005 Decoma shareholders will receive either 0.1453 shares of
Magna or $12.8279 in cash per share.
After the deal was announced, Decoma spiked as high as $14.40, which we
believed was an excellent price to receive for our shares. Unfortunately, we
were unable to sell our entire position in the $13.50 to $14.00 range in the
open market due to Decoma’s limited trading liquidity at this level.
However, we are quite pleased to take the $12.8279 per share of Decoma for
the balance of our position given our relatively short holding period for
this investment. As is sometimes the case, the story worked out much more
quickly than we had hoped.
|
|
|
 |
|
|
| INVESTOR RELATIONS CONTACT INFORMATION |
| Mailing Address : |
50 Casmir Court,
Concord, Ontario, Canada L4K 4J5 |
| Phone : |
905-669-2888 |
Web Address : |
www.decoma.com |
| Fax : |
905-669-5075 |
Email : |
info@decoma.com
|
|
|
 |
|
|
| LINKS TO OTHER INFORMATION |
| Quotes |
News |
Profile |
Filings |
|
|
|
 |
|
|
|
|
|
|